ID: ALA1159476

Max Phase: Preclinical

Molecular Formula: C6H12O5S

Molecular Weight: 196.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](CS)[C@H]1O

Standard InChI:  InChI=1S/C6H12O5S/c7-3-2(1-12)11-6(10)5(9)4(3)8/h2-10,12H,1H2/t2-,3-,4+,5-,6+/m1/s1

Standard InChI Key:  OMLRWUJGVBOYQP-DVKNGEFBSA-N

Associated Targets(Human)

Brain glycogen phosphorylase 474 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 196.22Molecular Weight (Monoisotopic): 196.0405AlogP: -2.28#Rotatable Bonds: 1
Polar Surface Area: 90.15Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.90CX Basic pKa: CX LogP: -1.84CX LogD: -1.84
Aromatic Rings: 0Heavy Atoms: 12QED Weighted: 0.30Np Likeness Score: 2.12

References

1. Cruciani G, Watson KA..  (1994)  Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b.,  37  (16): [PMID:8057302] [10.1021/jm00042a012]

Source